NOTE: This order is nonprecedential

United States Court of Appeals for the Federal Circuit

THERASENSE, INC. (NOW KNOWN AS ABBOTT DIABETES CARE, INC.) AND ABBOTT f LABORATORIES, Plaintiffs-Appellants,

V.

BECTON, DICKINSON AND COMPANY AND NOVA BIOMEDICAL CORPORATION, Defendants-Cross Appellants,

AND

BAYER HEALTHCARE LLC, Defendant-Appellee.

2012-1365, -1503, -1504

Appeals from the United States Distri_ct Court for the Northern District of California in consolidated case nos. 04-CV-2123, 04-CV-3327, 04-CV-3732, and 05-CV-3117, Judge William H. Alsup.

ON MOTION

ORDER

THERASENSE, INC. V. BECTON, DICKINSON AND COMPANY 2

Therasense, Inc. (noW known as Abbott Diabetes Care, Inc.) and Abbott Laboratories move for a 30-day extension of time, until October 1, 2012, to file its opening brief. Becton, Dickinson and Company, and Nova Bio- medical Corp. oppose.

Upon consideration thereof, IT ls ORDERED THAT:

The motion is granted

FoR THE CoURT

AUG 1 7 2012 /s/ Jan Horbaly Date J an Horbal§_f Clerk

cc: Clara J. Shin, Esq. LED

Rachel Krevans, Esq. u_s_ coun-l[:!); AppEALS \:g;;

Byadf()yd Badke, ESq_ THE FEDER,C.L CZL~\CU\T 821 AUG l 7'[1`)1'£

JAN HUHBALY

CLERK